Kallioniemi O - Search Results

1

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T. Catto JW, et al. Among authors: kallioniemi o. Eur Urol. 2011 May;59(5):671-81. doi: 10.1016/j.eururo.2011.01.044. Epub 2011 Feb 1. Eur Urol. 2011. PMID: 21296484 Review.

2

miR-183 in prostate cancer cells positively regulates synthesis and serum levels of prostate-specific antigen.

Larne O, Östling P, Haflidadóttir BS, Hagman Z, Aakula A, Kohonen P, Kallioniemi O, Edsjö A, Bjartell A, Lilja H, Lundwall Å, Ceder Y. Larne O, et al. Among authors: kallioniemi o. Eur Urol. 2015 Oct;68(4):581-8. doi: 10.1016/j.eururo.2014.12.025. Epub 2014 Dec 30. Eur Urol. 2015. PMID: 25556023

3

Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade.

Palmberg C, Koivisto P, Hyytinen E, Isola J, Visakorpi T, Kallioniemi OP, Tammela T. Palmberg C, et al. Among authors: kallioniemi op. Eur Urol. 1997;31(2):216-9. doi: 10.1159/000474453. Eur Urol. 1997. PMID: 9076469

4

Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.

Palmberg C, Koivisto P, Kakkola L, Tammela TL, Kallioniemi OP, Visakorpi T. Palmberg C, et al. Among authors: kallioniemi op. J Urol. 2000 Dec;164(6):1992-5. J Urol. 2000. PMID: 11061898

5

New prognostic factors in prostatic carcinoma.

Visakorpi T, Kallioniemi OP, Koivula T, Isola J. Visakorpi T, et al. Among authors: kallioniemi op. Eur Urol. 1993;24(4):438-49. doi: 10.1159/000474347. Eur Urol. 1993. PMID: 8287885 Review. No abstract available.

6

Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer.

Koivisto P, Visakorpi T, Kallioniemi OP. Koivisto P, et al. Among authors: kallioniemi op. Scand J Clin Lab Invest Suppl. 1996;226:57-63. Scand J Clin Lab Invest Suppl. 1996. PMID: 8981668 Review.

7

Androgen receptor gene and hormonal therapy failure of prostate cancer.

Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP. Koivisto P, et al. Among authors: kallioniemi op. Am J Pathol. 1998 Jan;152(1):1-9. Am J Pathol. 1998. PMID: 9422516 Free PMC article. Review.

8

Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.

Östling P, Leivonen SK, Aakula A, Kohonen P, Mäkelä R, Hagman Z, Edsjö A, Kangaspeska S, Edgren H, Nicorici D, Bjartell A, Ceder Y, Perälä M, Kallioniemi O. Östling P, et al. Among authors: kallioniemi o. Cancer Res. 2011 Mar 1;71(5):1956-67. doi: 10.1158/0008-5472.CAN-10-2421. Epub 2011 Feb 22. Cancer Res. 2011. PMID: 21343391

9

Genetic basis and clonal evolution of human prostate cancer.

Kallioniemi OP, Visakorpi T. Kallioniemi OP, et al. Adv Cancer Res. 1996;68:225-55. doi: 10.1016/s0065-230x(08)60355-3. Adv Cancer Res. 1996. PMID: 8712069 Review. No abstract available.

10

[ Hereditary prostate cancer with gene location].

Matikainen M, Schleutker J, Visakorpi T, Kallioniemi OP. Matikainen M, et al. Among authors: kallioniemi op. Duodecim. 1997;113(6):461-2. Duodecim. 1997. PMID: 11370066 Finnish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

421 results

Search Page

Filters